Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10517876 Oxygen linked pyrimidine derivatives

Patent 10517876 was granted and assigned to CTI BioPharma on December, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Harish Kumar Mysore Nagaraj0

Eric T. Sun0

Yee Ling Evelyn Tan0

Stephanie Blanchard0

Anders Poulsen0

Anthony Deodaunia William0

Cheng Hsia Angeline Lee0

Date of Patent

December 31, 2019

0

Patent Application Number

153988510

Date Filed

January 5, 2017

0

Patent Primary Examiner

Noble E Jarrell

0

Patent abstract

The present invention relates to pyrimidine compounds that are useful as anti-proliferative agents. More particularly, the present invention relates to oxygen linked and substituted pyrimidine compounds, methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment of proliferative disorders. These compounds may be useful as medicaments for the treatment of a number of proliferative disorders including tumours and cancers as well as other disorders or conditions related to or associated with kinases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10517876 Oxygen linked pyrimidine derivatives

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.